FrancophonIA/ELRC3.0 huggingface dataset:
English: Patients and carers should be made aware that behavioural symptoms of impulse control disorders including pathological gambling, increased libido, hypersexuality, compulsive spending or buying, binge eating and compulsive eating can occur in patients treated with dopamine agonists including MIRAPEXIN.
Danish: Patienter og pårørende bør informeres om, at adfærdsmæssige symptomer på manglende impulskontrol herunder ludomani, forøget libido, hyperseksualitet, tvangshandlinger, der fører til overdrevent indkøbsmønster og uhæmmet og overdreven madindtagelse, kan forekomme hos patienter i behandling med dopaminagonister, herunder Mirapexin.
English: In patients with a creatinine clearance between 30 and 50 ml/min, treatment should be started with 0.26 mg MIRAPEXIN prolonged-release tablets every other day.
Danish: Ved kreatininclearance mellem 30 og 50 ml/min bør behandlingen starte med 0,26 mg Mirapexin depottabletter hver anden dag.
English: In a clinical trial with healthy volunteers, where MIRAPEXIN prolonged-release tablets were titrated faster (every 3 days) than recommended up to 3.15 mg pramipexole base (4.5 mg of salt) per day, an increase in blood pressure and heart rate was observed.
Danish: I et klinisk studie med raske frivillige forsøgspersoner, hvor dosisjustering af Mirapexin depottabletter var hurtigere (hver 3. dag) end anbefalet, op til 3,15 mg pramipexolbase (4,5 mg salt)/dag, blev der observeret en stigning i blodtrykket samt en forøgelse af hjerterytmen.
English: If you are switching from MIRAPEXIN (immediate release) tablets Your doctor will base your dose of MIRAPEXIN prolonged-release tablets on the dose of MIRAPEXIN (immediate release) tablets you were taking.
Danish: Hvis du skifter fra almindelige MIRAPEXIN tabletter Din læge vil basere din dosis af MIRAPEXIN depottabletter på den dosis af almindelige MIRAPEXIN tabletter, som du hidtil har taget.
English: MIRAPEXIN can reduce the production of breast milk.
Danish: MIRAPEXIN kan nedsætte mælkeproduktionen og kan også overføres til din baby via brystmælk.
English: A decreased body weight by 30 kg results in an increase in
Danish: Et vægttab på 30 kg viste en Cmax-stigning på 45%.
English: - Binge eating (eating large amounts of food in a short time period) or compulsive eating (eating more food than normal and more than is needed to satisfy your hunger)* - Delirium (decreased awareness, confusion, loss of reality)
Danish: - Uhæmmet madindtagelse (spise store mængder mad i en kort periode) eller overdreven madindtagelse (spise mere mad end sædvanligt og mere end nødvendigt for at dække sulten)*
English: Do not stop taking MIRAPEXIN without first talking to your doctor.
Danish: Du må ikke holde op med at tage MIRAPEXIN uden at spørge din læge til råds.
English: Tablets are scored on both sides and breakable in halves.
Danish: Tabletterne har delekærv på begge sider og kan deles i to lige store dele.
English: The efficacy and tolerability of an overnight switch from MIRAPEXIN tablets to MIRAPEXIN prolonged-release tablets at the same daily dose were evaluated in a double-blind clinical study in patients with early Parkinson's disease.
Danish: Virkningen og tolerabiliteten hos patienter, som fra dag til dag skiftede behandling fra Mirapexin tabletter til Mirapexin depottabletter, blev undersøgt i et dobbelblindt klinisk studie hos patienter med tidlig udvikling af Parkinsons sygdom.
English: MIRAPEXIN with food, drink and alcohol You should be cautious while drinking alcohol during treatment with MIRAPEXIN.
Danish: Brug af MIRAPEXIN sammen med mad, drikke og alkohol Ved behandling med MIRAPEXIN, skal du være forsigtig med indtagelse af alkohol, da din reaktionsevne kan blive markant nedsat.
English: 63% of patients on pramipexole and 52% of patients on placebo reported at least one adverse drug reaction.
Danish: 63% af patienterne i pramipexolbehandling og 52% af patienterne i placebobehandling rapporterede mindst én bivirkning.
English: All tablets have the Boehringer Ingelheim company symbol embossed on one side and the codes P6, P7, P8, or P9 on the other side, representing the tablet strengths 0.088 mg, 0.18 mg, 0.35 mg, and 0.7 mg, respectively.
Danish: Alle tabletter har Boehringer Ingelheims firma logo præget på den ene side og koden P6, P7, P8 eller P9 på den anden, hvilket repræsenterer tabletstyrker på henholdsvis 0,088 mg, 0,18 mg, 0,35mg og 0,7 mg.
English: MIRAPEXIN should not be used during breast-feeding.
Danish: MIRAPEXIN må ikke anvendes under amning.
English: - Severe heart or blood vessels disease.
Danish: • Alvorlige hjerte- eller karsygdomme.
English: nd week rd week th week
Danish: 1 gang daglig Aften dosis
English: MIRAPEXIN is not recommended for use in children and adolescents below 18 years due to a lack of data on safety and efficacy.
Danish: Mirapexin anbefales ikke til børn og unge under 18 år p.g.a. manglende dokumentation for sikkerhed og virkning.
English: The daily dose should not exceed 6 tablets MIRAPEXIN 0.088 mg or a dose of 0.54 mg (0.75 mg pramipexole salt).
Danish: Den daglige dosis bør ikke overstige 6 MIRAPEXIN tabletter á 0,088 mg eller en dosis af 0,54 mg (0,75 mg pramipexolsalt)
English: Do not store above 30°C.
Danish: Må ikke opbevares ved temperaturer over 30 C.
English: The European Medicines Agency has waived the obligation to submit the results of studies with MIRAPEXIN in all subsets of the paediatric population in Parkinson's Disease (see section 4.2 for information on paediatric use).
Danish: Det Europæiske Lægemiddelagentur har dispenseret fra kravet om at fremlægge resultaterne af studier med Mirapexin i alle undergrupper af den pædiatriske population med Parkinsons sygdom (se pkt.
English: If you stop taking MIRAPEXIN
Danish: Hvis du holder op med at tage MIRAPEXIN
English: If you forget to take MIRAPEXIN
Danish: Hvis du har glemt at tage MIRAPEXIN
English: Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.
Danish: DATO FOR ÆNDRING AF TEKSTEN Yderligere oplysninger om dette lægemiddel findes på Det Europæiske Lægemiddelagenturs hjemmeside http://www.ema.europa.eu og på Lægemiddelstyrelsens hjemmeside http://www.laegemiddelstyrelsen.dk.
English: The safety and efficacy of MIRAPEXIN in children below 18 years has not been established.
Danish: Mirapexins sikkerhed og virkning hos børn under 18 år er ikke klarlagt.
English: Store in the original package to protect the tablets from light.
Danish: Opbevares i den originale yderpakning for at beskytte tabletterne mod lys.
English: MIRAPEXIN can be taken with or without food.
Danish: MIRAPEXIN kan enten tages sammen med mad eller alene.
English: Because of possible additive effects, caution should be advised when patients are taking other sedating medicinal products or alcohol in combination with pramipexole (see sections 4.4, 4.7 and 4.8).
Danish: På grund af en mulig additiv virkning, bør forsigtighed udvises, når patienter tager andre sedative lægemidler eller alkohol i kombination med pramipexol (se pkt.
English: MIRAPEXIN is not recommended for use in children and adolescents below 18 years since the efficacy and safety has not been established in this population.
Danish: Mirapexin anbefales ikke til børn og unge under 18 år, da sikkerhed og virkning ikke er klarlagt hos denne population.
English: Patients already taking MIRAPEXIN tablets may be switched to MIRAPEXIN prolonged-release tablets overnight, at the same daily dose.
Danish: Patienter, der i forvejen tager Mirapexin tabletter, kan fra dag til dag skifte til den samme daglige dosis af Mirapexin depottabletter.
English: When the intake of a dose is missed, MIRAPEXIN prolonged-release tablets should be taken within 12 hours after the regularly scheduled time.
Danish: Hvis patienten glemmer en dosis, bør Mirapexin depottabletter tages indenfor 12 timer fra det sædvanlige tidspunkt.
English: 6.5 Nature and contents of container OPA/aluminium/PVC-aluminium blisters.
Danish: 6.5 Emballagetype og pakningsstørrelser OPA/aluminium/PVC-aluminium blister.
English: There is no relevant use of MIRAPEXIN in the paediatric population for the indication of Parkinson's Disease.
Danish: Det er ikke relevant at anvende Mirapexin hos den pædiatriske population ved indikationen Parkinsons sygdom.
English: What MIRAPEXIN contains
Danish: MIRAPEXIN indeholder:
English: The recommended starting dose of MIRAPEXIN is 0.088 mg of base (0.125 mg of salt) taken once daily 2-3 hours before bedtime.
Danish: Den anbefalede startdosis for Mirapexin er 0,088 mg base (0,125 mg salt), som tages 1 gang dagligt 23 timer før sengetid.
English: Pathological gambling, increased libido, hypersexuality, compulsive spending or buying, binge eating and compulsive eating can occur in patients treated with dopamine agonists including MIRAPEXIN (see section 4.4).
Danish: Ludomani, forøget libido, hyperseksualitet og tvangshandlinger, der fører til overdrevent indkøbsmønster og uhæmmet og overdreven madindtagelse, kan forekomme hos patienter i behandling med dopaminagonister, herunder Mirapexin (se pkt.
English: What MIRAPEXIN is and what it is used for
Danish: MIRAPEXIN bruges til
English: A precise frequency estimation is not possible as the side effect did not occur in a clinical trial database of 1,395 patients with Restless Legs Syndrome treated with pramipexole
Danish: En præcis estimering af frekvens er ikke mulig, da bivirkningen ikke fandtes i en database med data for kliniske forsøg med 1.395 patienter med Restless Legs syndrom behandlet med pramipexol.
English: MIRAPEXIN 1.05 mg, 1.57 mg, 2.1 mg, 2.62 mg and 3.15 mg prolonged-release tablets are white to off-white and of oval shape.
Danish: MIRAPEXIN 1,05 mg, 1,57 mg, 2,1 mg, 2,62 mg og 3,15 mg depottabletter er hvide til råhvide og ovale.
English: If you take more MIRAPEXIN than you should If you accidentally take too many tablets, - Contact your doctor or nearest hospital casualty department immediately for advice.
Danish: Hvis du har taget for mange MIRAPEXIN tabletter Hvis du har taget for mange MIRAPEXIN tabletter, så kontakt lægen eller skadestuen med det samme.
English: Each blister strip contains 10 prolonged-release tablets.
Danish: Hvert blisterkort indeholder 10 depottabletter.
English: - treat the symptoms of moderate to severe primary Restless Legs Syndrome in adults.
Danish: • behandling af voksne patienter med symptomer på moderat til svær restless legs syndrom (RLS),
English: Symptoms suggestive of neuroleptic malignant syndrome have been reported with abrupt withdrawal of dopaminergic therapy (see section 4.2).
Danish: Symptomer, der ligner malignt neuroleptikasyndrom, har været set i forbindelse med pludseligt ophør med dopaminbehandling (se pkt.
English: The mean change from baseline in the Restless Legs Syndrome Rating Scale (IRLS) and the Clinical Global Impression-Improvement (CGI-I) were the primary efficacy outcome measures.
Danish: De primære virknings-parametre var gennemsnitsændringen fra baseline af restless legs syndrom Rating Scale (IRLS) og Clinical Global Impression-Improvement (CGI-I).
English: During the first week, the usual dose is 1 tablet MIRAPEXIN 0.088 mg three times a day (equivalent to 0.264 mg daily):
Danish: I den første uge er dosis oftest 1 MIRAPEXIN tablet á 0,088 mg tre gange dagligt (svarende til 0,264 mg om dagen):
English: Patients must be informed of this and advised to exercise caution while driving or operating machines during treatment with MIRAPEXIN.
Danish: Patienterne bør informeres om dette, og rådes til forsigtighed ved bilkørsel og betjening af maskiner.
English: Cartons containing 3 or 10 blister strips (30 or 100 tablets).
Danish: Kartoner indeholdende 3 eller 10 blisterkort (30 eller 100 tabletter).
English: The daily dose is administered in equally divided doses 3 times a day.
Danish: Den daglige dosis skal deles i 3 lige store doser.
English: MIRAPEXIN contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain.
Danish: MIRAPEXIN indeholder det aktive stof pramipexol, der er en såkaldt dopaminagonist, som stimulerer specielle receptorer i hjernen (dopaminreceptorerne).
English: There is no relevant use of MIRAPEXIN prolonged-release tablets in the paediatric population for the indication of Parkinson's Disease.
Danish: Det er ikke relevant at anvende Mirapexin depottabletter hos den pædiatriske population ved indikationen Parkinsons sygdom.
English: All tablets have the Boehringer Ingelheim company symbol embossed on one side and the codes P1, P2, P3, P12, P4, P13, or P5 on the other side, representing the tablet strengths 0.26 mg, 0.52 mg, 1.05 mg, 1.57 mg, 2.1 mg, 2.62 mg and 3.15 mg, respectively.
Danish: Alle tabletter har Boehringer Ingelheim firma symbol præget på den ene side og koden P1, P2, P3, P12, P4, P13 eller P5 på den anden side gældende for tablet styrkerne 0,26 mg, 0,52 mg, 1,05 mg, 1,57 mg, 2,1 mg, 2,62 mg og 3,15 mg.
English: Restless Legs Syndrome, most common adverse reactions The most commonly (≥ 5%) reported adverse drug reactions in patients with Restless Legs Syndrome treated with pramipexole were nausea, headache, dizziness and fatigue.
Danish: Almindeligste bivirkninger ved restless legs syndrom De mest almindeligt ( 5%) rapporterede bivirkninger hos patienter med restless legs syndrom, er kvalme, hovedpine, svimmelhed og træthed.
English: What you need to know before you take MIRAPEXIN
Danish: Det skal du vide, før du begynder at tage MIRAPEXIN
English: st week
Danish: 1. uge
English: Each tablet contains 0.26 mg, 0.52 mg, 1.05 mg, 1.57 mg, 2.1 mg, 2.62 mg, or 3.15 mg pramipexole as 0.375 mg, 0.75 mg, 1.5 mg, 2.25 mg, 3 mg, 3.75 mg, or 4.5 mg pramipexole dihydrochloride monohydrate, respectively.
Danish: Hver tablet indeholder 0,26 mg, 0,52 mg, 1,05 mg, 1,57 mg, 2,1 mg, 2,62 mg eller 3,15 mg pramipexol som henholdsvis 0,375 mg, 0,75 mg, 1,5 mg, 2,25 mg, 3 mg, 3,75 mg eller 4,5 mg pramipexoldihydrochloridmonohydrat.
English: Pramipexole is commonly associated with somnolence and has been associated uncommonly with excessive daytime somnolence and sudden sleep onset episodes (see also section 4.4).
Danish: Det er almindeligt, at pramipexolbehandling er forbundet med døsighed, men det er ikke almindeligt, at det er forbundet med somnolens (søvnlignende bevidsthedssvækkelse) i dagtimerne og pludseligt opståede søvnepisoder (se også pkt.
English: Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.
Danish: MIRAPEXIN påvirker nerveimpulser i hjernen, som kontrollerer kroppens bevægelser, ved at stimulere dopaminreceptorerne.
English: In patients with a creatinine clearance between 20 and 50 ml/min, the initial daily dose of MIRAPEXIN should be administered in two divided doses, starting at 0.088 mg of base (0.125 mg of salt) twice a day (0.176 mg of base/0.25 mg of salt daily).
Danish: • Ved kreatininclearance mellem 20 og 50 ml/min bør initialdosis af Mirapexin fordeles på 2 daglige doser begyndende med 0,088 mg base (0,125 mg salt) to gange dagligt svarende til 0,176 mg base (0,25 mg salt)/dag.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING Folding box
Danish: MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE KARTON
English: Each tablet contains 0.088 mg, 0.18 mg, 0.35 mg, or 0.7 mg pramipexole as 0.125 mg, 0.25 mg, 0.5 mg, or 1 mg pramipexole dihydrochloride monohydrate, respectively.
Danish: Hver tablet indeholder 0,088 mg, 0,18 mg, 0,35 mg eller 0,7 mg pramipexol som henholdsvis 0,125 mg, 0,25 mg, 0,5 mg eller 1 mg pramipexoldihydrochloridmonohydrat.
English: MIRAPEXIN 0.18 mg tablets and MIRAPEXIN 0.35 mg tablets are white, of oval shape, and flat.
Danish: MIRAPEXIN 0,18 mg og MIRAPEXIN 0,35 mg er hvide, ovale og flade tabletter.
English: - Psychosis (e.g. comparable with symptoms of schizophrenia) - Vision impairment.
Danish: • Psykoser (f.eks. som ved symptomer på skizofreni)
English: In a double-blind placebo-controlled trial including a total of 517 patients with advanced Parkinson's disease who were on concomitant levodopa therapy superiority of MIRAPEXIN prolonged-release tablets over placebo was demonstrated after 18 weeks of treatment on both the primary (UPDRS Parts II+III score) and the key secondary (off-time) efficacy endpoints.
Danish: Et dobbeltblindet, placebokontrolleret studie med 539 patienter med tidlig Parkinsons sygdom viste, at Mirapexin depottabletter havde en bedre virkning (superior) end placebo efter 18 ugers behandling på både det primære (UPDRS del II+III score) og vigtigste sekundære (CGI-I og PGI-I responderhastigheder) endepunkter.
English: The tablets should be taken orally, swallowed with water, and can be taken either with or without food.
Danish: MIRAPEXIN tabletter bør synkes med vand, og kan både tages sammen med eller uden mad.
English: MIRAPEXIN can cause hallucinations (seeing, hearing or feeling things that are not there).
Danish: • Hallucinationer (ser, hører eller føler ting, som ikke er der).
English: MIRAPEXIN is indicated in adults for treatment of the signs and symptoms of idiopathic Parkinson's disease, alone (without levodopa) or in combination with levodopa, i.e. over the course of the disease, through to late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or “on off” fluctuations).
Danish: Mirapexin kan gives, som monoterapi eller i kombination med levodopa i hele sygdomsforløbet herunder i de sene stadier, når virkningen af levodopa klinger af eller bliver ustabil, og svingninger i den terapeutiske virkning opstår.
English: If a further dose increase is necessary, doses should be increased by 0.26 mg pramipexole base at weekly intervals up to a maximum dose of 1.57 mg pramipexole base (2.25 mg of salt) per day.
Danish: Hvis yderligere dosisøgning er nødvendig, bør dosis øges med 0,26 mg pramipexolbase/uge op til en maksimal dosis på 1,57 mg pramipexolbase (2,25 mg salt)/dag.
English: If you have moderate kidney disease, the usual starting dose is 1 tablet MIRAPEXIN 0.088 mg twice a day.
Danish: Hvis din nyresygdom er moderat, er startdosis oftest 1 MIRAPEXIN tablet á 0,088 mg 2 gange daglig.
English: Very common may affect more than 1 in 10 people Common may affect up to 1 in 10 people
Danish: Bivirkningerne kan forekomme med en given hyppighed, som defineres på følgende måde: Meget almindelig Kan forekomme hos flere end 1 ud af 10 patienter Almindelig
English: Ascending dose schedule of MIRAPEXIN prolonged-release tablets Week Daily dose (mg of base)
Danish: Skema for øgning af dosis for Mirapexin depottabletter Uge Døgndosis (mg base) Døgndosis (mg salt)
English: Not known: - After stopping or reducing your MIRAPEXIN treatment: Depression, apathy, anxiety, fatigue,
Danish: Ikke kendt: - Efter at du er holdt op med eller har reduceret din MIRAPEXIN-behandling: Depression, apati, angst, træthed, svedtendens eller smerter kan forekomme (kaldet dopaminagonistabstinenssyndrom eller DAWS).
English: Parkinson's disease, most common adverse reactions The most commonly (≥ 5%) reported adverse drug reactions in patients with Parkinson's disease more frequent with pramipexole treatment than with placebo were nausea, dyskinesia, hypotension, dizziness, somnolence, insomnia, constipation, hallucination, headache and fatigue.
Danish: Almindeligste bivirkninger ved Parkinsons sygdom De mest almindeligt ( 5%) rapportede bivirkninger hos patienter med Parkinsons sygdom, som oftere ses efter behandling med pramipexol end efter behandling med placebo er kvalme, dyskinesi, hypotension, svimmelhed, døsighed, søvnløshed, forstoppelse, hallucinationer, hovedpine og træthed.
English: Cartons containing 1, 3 or 10 blister strips (10, 30 or 100 prolonged-release tablets).
Danish: Kartoner indeholdende 1,3 eller 10 blisterkort (10, 30 eller 100 depottabletter).
English: Nervous system disorders somnolence dizziness dyskinesia headache sudden onset of sleep amnesia hyperkinesia syncope
Danish: Nervesystemet døsighed, svimmelhed, dyskinesi hovedpine somnolens (søvnlignende bevidsthedssvækkelse), pludselig opstået søvn, amnesi, hyperkinesi, synkope
English: 1 tablet MIRAPEXIN 0.7 mg and 1 tablet MIRAPEXIN 0.35 mg three times a day
Danish: 1 MIRAPEXIN tablet á 0,7 mg og 1 MIRAPEXIN tablet á 0,35 mg 3 gange om dagen
English: Boehringer Ingelheim International GmbH D-55216 Ingelheim am Rhein Germany
Danish: Indehaver af markedsføringstilladelsen Boehringer Ingelheim International GmbH D-55216 Ingelheim am Rhein Tyskland
English: General disorders and administration site conditions fatigue peripheral oedema
Danish: Almene symptomer og reaktioner på administrationsstedet træthed perifere ødemer
English: MARKETING AUTHORISATION NUMBER(S) MIRAPEXIN 0.26 mg prolonged-release tablets EU/1/97/051/013-015
Danish: MARKEDSFØRINGSTILLADELSESNUMMER (-NUMRE) Mirapexin 0,26 mg depottabletter EU/1/97/051/013-015
English: In patients with a creatinine clearance less than 20 ml/min, the daily dose of MIRAPEXIN should be administered in a single dose, starting at 0.088 mg of base (0.125 mg of salt) daily.
Danish: • Ved kreatininclearance mindre end 20 ml/min bør Mirapexin gives som en enkeltdosis begyndende med 0,088 mg base (0,125 mg salt) per døgn.
English: MIRAPEXIN 0.7 mg tablets are white, of round shape, and flat.
Danish: MIRAPEXIN 0,7 mg er hvide, runde og flade tabletter.
English: CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE
Danish: B. BETINGELSER ELLER BEGRÆNSNINGER VEDRØRENDE UDLEVERING OG
English: In advanced Parkinson's disease, in combination treatment with levodopa, dyskinesia can occur during the initial titration of MIRAPEXIN.
Danish: Ved fremskreden Parkinsons sygdom kan dyskinesi forekomme i optitreringsfasen med Mirapexin, når det gives i kombination med levodopa.
English: Dopamine agonist withdrawal syndrome including apathy, anxiety, depression, fatigue, sweating and pain
Danish: Dopaminagonistabstinenssyndrom inklusive apati, angst, depression, træthed, svedtendens, smerter
English: Pramipexole should be tapered off at a rate of 0.52 mg of base (0.75 mg of salt) per day until the daily dose has been reduced to 0.52 mg of base (0.75 mg of salt).
Danish: Ppramipexoldosis bør reduceres med 0,52 mg base (0,75 mg salt)/dag, indtil den daglige dosis er reduceret til 0,52 mg base (0,75 mg salt).
English: MIRAPEXIN 0.088 mg tablets MIRAPEXIN 0.18 mg tablets MIRAPEXIN 0.35 mg tablets MIRAPEXIN 0.7 mg tablets
Danish: Mirapexin 0,088 mg tabletter Mirapexin 0,18 mg tabletter Mirapexin 0,35 mg tabletter Mirapexin 0,7 mg tabletter
English: Pramipexole should be tapered off at a rate of 0.54 mg of base (0.75 mg of salt) per day until the daily dose has been reduced to 0.54 mg of base (0.75 mg of salt).
Danish: Pramipexoldosis bør reduceres med 0,54 mg base (0,75 mg salt)/dag, indtil den daglige dosis er reduceret til 0,54 mg base (0,75 mg salt).
English: MIRAPEXIN is used to treat the symptoms of primary Parkinson's disease in adults.
Danish: MIRAPEXIN bruges til behandling af voksne patienter med symptomer på Parkinsons sygdom.
English: Swallow the tablets whole with water.
Danish: MIRAPEXIN tabletter skal synkes hele med vand.
English: How to take MIRAPEXIN
Danish: Sådan skal du tage MIRAPEXIN
English: MIRAPEXIN 0.26 mg prolonged-release tablets MIRAPEXIN 0.52 mg prolonged-release tablets MIRAPEXIN 1.05 mg prolonged-release tablets MIRAPEXIN 1.57 mg prolonged-release tablets MIRAPEXIN 2.1 mg prolonged-release tablets MIRAPEXIN 2.62 mg prolonged-release tablets MIRAPEXIN 3.15 mg prolonged-release tablets
Danish: MIRAPEXIN 0,26 mg depottabletter MIRAPEXIN 0,52 mg depottabletter MIRAPEXIN 1,05 mg depottabletter MIRAPEXIN 1,57 mg depottabletter MIRAPEXIN 2,1 mg depottabletter MIRAPEXIN 2,62 mg depottabletter MIRAPEXIN 3,15 mg depottabletter pramipexol
English: It is recommended that the dose of levodopa is reduced during both the dose escalation and the maintenance treatment with MIRAPEXIN, depending on reactions in individual patients (see section
Danish: Afhængigt af den enkelte patients respons på behandlingen kan det anbefales, at levodopadosis reduceres både under dosisstigning og vedligeholdelsesbehandling med Mirapexin (se pkt.